Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from NAV-005, a high-affinity MUC16/CA125 antagonist for the treatment of humoral immunosuppressed cancers. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1177/172460089801300402
10.1177/172460089801300402 · 1998 · External reference
10.1111/j.1365-2257.2004.00655.x
10.1111/j.1365-2257.2004.00655.x · 2005 · External reference
Unresolved reference
1991 · External reference
10.1054/bjoc.2000.1174
10.1054/bjoc.2000.1174 · 2000 · External reference
10.3390/cancers12123730
10.3390/cancers12123730 · 2020 · External reference
10.1007/bf00931382
10.1007/bf00931382 · 1989 · External reference
10.1177/172460089801300405
10.1177/172460089801300405 · 1998 · External reference
10.1177/172460089801300406
10.1177/172460089801300406 · 1998 · External reference
Unresolved reference
2022 · External reference
10.1016/j.ygyno.2005.07.030
10.1016/j.ygyno.2005.07.030 · 2005 · External reference
10.18632/oncotarget.19090
10.18632/oncotarget.19090 · 2018 · External reference
10.1159/000481213
10.1159/000481213 · 2017 · External reference
10.1002/eji.201847707
10.1002/eji.201847707 · 2018 · External reference
10.1158/2326-6066.cir-15-0120
10.1158/2326-6066.cir-15-0120 · 2015 · External reference
10.1634/theoncologist.2008-0089
10.1634/theoncologist.2008-0089 · 2008 · External reference
10.3390/ijms160716414
10.3390/ijms160716414 · 2015 · External reference
10.1016/j.breast.2021.08.007
10.1016/j.breast.2021.08.007 · 2021 · External reference
Unresolved reference
2002 · External reference
10.1186/1476-4598-9-139
10.1186/1476-4598-9-139 · 2010 · External reference
10.1182/bloodadvances.2017006866
10.1182/bloodadvances.2017006866 · 2017 · External reference
10.1200/jco.2015.63.2596
10.1200/jco.2015.63.2596 · 2016 · External reference
10.1007/s10875-012-9662-7
10.1007/s10875-012-9662-7 · 2012 · External reference
Unresolved reference
2003 · External reference
10.1016/j.cell.2022.02.012
10.1016/j.cell.2022.02.012 · 2022 · External reference
10.1038/srep01870
10.1038/srep01870 · 2013 · External reference
10.7150/jca.2.280
10.7150/jca.2.280 · 2011 · External reference
Unresolved reference
2007 · External reference
10.1016/j.lungcan.2009.07.016
10.1016/j.lungcan.2009.07.016 · 2010 · External reference
10.1080/15384047.2018.1449614
10.1080/15384047.2018.1449614 · 2018 · External reference
10.1371/journal.pone.0285161
10.1371/journal.pone.0285161 · 2023 · External reference
10.1007/978-1-4939-9929-3_3
10.1007/978-1-4939-9929-3_3 · 2020 · External reference
10.1074/jbc.m806776200
10.1074/jbc.m806776200 · 2009 · External reference
10.1158/0008-5472.can-15-1795
10.1158/0008-5472.can-15-1795 · 2016 · External reference
10.1002/eji.202451611
10.1002/eji.202451611 · 2025 · External reference
10.1016/j.xcrm.2024.101792
10.1016/j.xcrm.2024.101792 · 2024 · External reference
10.3389/fimmu.2022.913215
10.3389/fimmu.2022.913215 · 2022 · External reference
10.3390/ijms22168947
10.3390/ijms22168947 · 2021 · External reference
10.1016/j.str.2024.04.011
10.1016/j.str.2024.04.011 · 2024 · External reference
10.1007/s12185-012-1102-1
10.1007/s12185-012-1102-1 · 2012 · External reference
10.3390/cancers12123730
10.3390/cancers12123730 · 2020 · External reference
10.18632/oncotarget.19246
10.18632/oncotarget.19246 · 2017 · External reference
10.1016/j.humpath.2012.01.005
10.1016/j.humpath.2012.01.005 · 2012 · External reference
10.1093/abt/tbaf008
10.1093/abt/tbaf008 · 2025 · External reference
Unresolved reference
2019 · External reference
10.4155/bio-2016-0179
10.4155/bio-2016-0179 · 2016 · External reference
